logo

For the Inventor, By the Inventor

Baden, Austria

Ulrike Tontsch-Grunt

This inventor holds 11 USPTO granted patents and 9 published patent applications and 4 EPO patents. Top assignees: Boehringer Ingelheim Pharma Gmbh & Co Kg, Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharma Kg. Active years: 2004-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulrike Tontsch-Grunt. Retrieved from https://idiyas.com/inventor/ulrike-tontsch-grunt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 72.7

 

Average Co-Inventor Count = 7.2

ph-index = 6

Forward Citations = 130(Granted Patents)


Company Filing History:

goldMedal6 out of 194 
 
Boehringer Ingelheim Pharma Gmbh & Co Kg
 patents
silverMedal3 out of 1,562 
 
Boehringer Ingelheim International Gmbh
 patents
bronzeMedal2 out of 149 
 
Boehringer Ingelheim Pharma Kg
 patents

Years Active: 2004-2014

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 8623887 - Compounds (2014-01-07),
2. 8207179 - Substituted indolines as tyrosine kinase inhibitors (2012-06-26),
3. 7981880 - 3-(aminomethyliden) 2-indolinone derivates and their use as cell proliferation inhibitors (2011-07-19),
4. 7858616 - Indolinone derivatives substituted in the 6 position, their preparation and their use as medicaments (2010-12-28),
5. 7547703 - Indoline derivatives substituted in the 6-position, their preparation and their use as medicaments (2009-06-16),
6. 7514468 - Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions (2009-04-07),
7. 7169936 - Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments (2007-01-30),
8. 7148249 - Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments (2006-12-12),
9. 6855710 - Substituted indolines with an inhibitory effect on various kinases and complexes of CDKs (2005-02-15),
10. 6794395 - Substituted indolinones, their manufacture and their use as medicaments (2004-09-21),
11. 6762180 - Substituted indolines which inhibit receptor tyrosine kinases (2004-07-13),

Title: Trailblazer in Inventions: The Innovative Journey of Ulrike Tontsch-Grunt

Introduction: Ulrike Tontsch-Grunt, a distinguished inventor hailing from Baden, Austria, has left an indelible mark in the realm of technological advancements with his relentless pursuit of excellence and dedication to innovation.

Latest Patents: With a notable portfolio of 11 patents, Ulrike Tontsch-Grunt's latest inventions focus on compounds that serve as tyrosine kinase inhibitors, holding immense promise for the treatment of diseases characterized by abnormal cell proliferation.

Career Highlights: Having contributed significantly to the field of inventions, Ulrike Tontsch-Grunt has lent his expertise to renowned companies such as Boehringer Ingelheim Pharma GmbH & Co. KG and Boehringer Ingelheim International GmbH, where his innovative spirit thrived.

Collaborations: Throughout his illustrious career, Ulrike Tontsch-Grunt has collaborated with esteemed colleagues such as Gerald Juergen Roth and Armin Heckel, fostering a culture of innovation and pushing the boundaries of technological evolution.

Conclusion: Ulrike Tontsch-Grunt's visionary approach to inventions, coupled with his passion for pushing the boundaries of technological innovation, cements his status as a trailblazer in the world of inventions, inspiring generations of inventors to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…